ARCHIVES

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 34 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

ELM’s CHOP-DS Aims For 15% Of Patients

September 13, 1985

Ford To Resubmit Budget Slash Of $125 Million For NCI

January 3, 1975

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer

July 26, 2002

NI Selects15 Cancer Patient Advocates for Director’s Consumer Liaison Group

November 23, 1997

Amazon Links To NCI Materials, A First For NIH Health Content.

July 14, 2000